4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

SEC · Jul 19, 2024 09:36

Summary by Futu AI

Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.

Helpful

Not Helpful

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

Summary by Futu AI

Risk Disclaimer